A program to educate about lung cancer treatment options
Cancer research education program (C-REP)
This study is all about helping people with non-small cell lung cancer learn more about new treatments, like targeted therapies and immunotherapies, so they can make better choices about their care, especially with the help of genetic testing.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Icahn School of Medicine at Mount Sinai NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-11194543 on NIH RePORTER |
What this research studies
This research program focuses on improving education and awareness regarding lung cancer treatment, particularly for patients with non-small cell lung cancer (NSCLC). It aims to enhance understanding of novel therapies, including targeted therapies and immunotherapies, which can significantly impact patient outcomes. The program emphasizes the importance of genetic testing to identify eligible patients for these advanced treatments. By providing comprehensive information, the program seeks to empower patients and healthcare providers in making informed treatment decisions.
Who could benefit from this research
Good fit: Ideal candidates for this program are patients diagnosed with non-small cell lung cancer who may benefit from targeted therapies or immunotherapies.
Not a fit: Patients with lung cancer who do not have access to genetic testing or those with other types of lung cancer may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved patient outcomes through better-informed treatment choices for lung cancer.
How similar studies have performed: Previous research has shown that educational programs focused on cancer treatment can lead to better patient outcomes and increased awareness of available therapies.
Where this research is happening
New York, United States
- Icahn School of Medicine at Mount Sinai — New York, United States (Active)
Researchers
- Principal investigator: Benn, Emma Katherine Tara — Icahn School of Medicine at Mount Sinai
- Study coordinator: Benn, Emma Katherine Tara
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.